DDX39B and non-small cell lung carcinoma: Given the essential role of the DDX39B-TRIM28 interaction in TRIM28-mediated K63-linked polyubiquitination and the subsequent upregulation of DDX39B, we hypothesized that targeting this interaction could serve as a promising therapeutic strategy for NSCLC.